Correlation between serum interleukin-31 level and the severity of disease in children with atopic dermatitis

Postepy Dermatologii i Alergologii

Volumn 30, Issue 5, 2013, Pages 282-285

  Siniewicz Luzeńczyk, Katarzyna ^a   Stańczyk Przyłuska, Anna ^a   Zeman, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Atopic dermatitis; Children; Interleukin 31; Pruritus; SCORAD

Indexed keywords

INTERLEUKIN 31;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SKIN PRURITUS;

EID: 84891318729     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/pdia.2013.38356     Document Type: Article

References (19)

1. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol (Stockh) 1980; 92 Suppl.: 44-7.
2. Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 1994; 10: 11-8.
3. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993; 186: 23-31.
4. Ständer S, Steinhoff M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 2002; 11: 12-24.
5. Castellani ML, Salini V, Frydas S, et al. Interleukin-31: A new cytokine involved in inflammation of the skin. Int J Immunopathol Pharmacol 2006; 19: 1-4.
6. Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003; 374: 1-20.
7. Dillon SR, Sprecher C, Hammond A, et al. Intreleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5: 752-60.
8. Ghilardi N, Li J, Hongo JA, et al. A novel type I cytokine receptor is expressed on monocytes, signals proliferation, and activates STAT-3 and STAT-5. J Biol Chem 2002; 277: 16831-6.
9. Yamaoka K, Okayama Y, Kaminuma O, et al. Proteomic approach to FcepsilonRI aggregation-initiated signal transduction cascade in human mast cells. Int Arch Allergy Immunol 2009; 149: 73-6.
10. Nobbe S, Dziunycz P, Mühleisen B, et al. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm Venereol 2012; 92: 24-8.
11. Raap U, Wichmann K, Bruder M, et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 2008; 122: 421-3.
12. Metz S, Naeth G, Heinrich PC, et al. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors. J Biol Chem 2008; 283: 5985-95.
13. Venereau E, Diveu C, Grimaud L, et al. Definition and characterization of an inhibitor for interleukin-31. J Biol Chem 2010; 285: 14955-63.
14. Ezzat MH, Hasan ZE, Shaheen KY. Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring. J Eur Acad Dermatol Venereol 2011; 25: 334-9.
15. Kim S, Kim HJ, Yang HS, et al. IL-31 serum protein and tissue mRNA levels in patients with atopic dermatitis. Ann Dermatol 2011; 23: 468-73.
16. Nobbe S, Dziunycz P, Mühleisen B, et al. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. Acta Derm Venereol 2012; 92: 24-8.
17. Szegedi K, Kremer AE, Kezic S, et al. Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol 2012; 21: 431-6.
18. Neiss MM, Peters B, Dreuw A, et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 2006; 118: 930-7.
19. Grimstad O, Sawanobori Y, Vestergaard C, et al. Anti-interleukin-31- antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol 2009; 18: 35-43.